As of 2023, France's share of scientific publications among the world's 10% top-cited in drug discovery registered stability at 10.6%. The forecast from 2024 through 2028 shows a consistent level of 10.6%. The lack of year-on-year variation indicates a static trend over this period. Since there are no variations recorded for the current and the next five years, the CAGR also remains at zero, denoting no expected growth or decline within this timeframe.
Future trends to watch for include potential changes in research funding, international collaborations, and innovation in drug discovery technologies in France. Monitoring these factors could impact France's positioning in high-impact scientific publications.
